AlphaFold predicted structure
PGM1 · P36871

Mean pLDDT
97.1/ 100
Very high
562 residues
Confidence breakdown
- Very high(≥ 90)96%
- Confident(70–90)3%
- Low(50–70)1%
- Very low(< 50)0%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
phosphoglucomutase 1
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Acute rhabdomyolysis
BIALLELIC, autosomal or pseudoautosomalClefting
BIALLELIC, autosomal or pseudoautosomalCongenital disorders of glycosylation
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalGlycogen storage disease
BIALLELIC, autosomal or pseudoautosomalKetotic hypoglycaemia
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomal+4 more panels — install the extension to see the full list inline on any page.
PGM1-congenital disorder of glycosylation
ALG13-CDG
developmental and epileptic encephalopathy, 36
MPDU1-congenital disorder of glycosylation
RFT1-congenital disorder of glycosylation
disorder of glycogen metabolism
Glycogen storage disease due to glycogenin deficiency
Glycogen storage disease due to phosphoglucomutase deficiency
congenital disorder of deglycosylation 1
Alacrimia-choreoathetosis-liver dysfunction syndrome
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Phosphoglucomutase-1
Catalyzes the reversible isomerization of alpha-D-glucose 1-phosphate to alpha-D-glucose 6-phosphate (PubMed:15378030, PubMed:25288802). The mechanism proceeds via the intermediate compound alpha-D-glucose 1,6-bisphosphate (Probable) (PubMed:25288802). This enzyme participates in both the breakdown and synthesis of glucose (PubMed:17924679, PubMed:25288802)
PGM1 · P36871

Mean pLDDT
97.1/ 100
Very high
562 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0